Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...

Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, according to new research.

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them ...

This identified at a genomic scale the molecular requirements for parasites to grow ... provide insights into one other ...

An introduction to the diversity of single-celled eukaryotes, i.e., protozoans, that are parasites of humans, domestic, and wild animals. Lectures emphasize the morphology, physiology, and life cycles ...

The team developed a novel vaccine that contains an mRNA sequence for ribosomal protein L6 (RPL6), a highly conserved Plasmodium protein. This protein is expressed consistently while the parasites are ...

The approach is underpinned by the millions of years of evolution that led to the creation of proteins by Plasmodium falciparum, the unicellular protozoan parasite that causes malaria. The ...

enabling fast and efficient detection of malaria-causing parasites directly from blood samples. The QIAprep& Plasmodium Kit simplifies malaria research by enabling the detection of all five ...

To protect themselves from that fate, the parasites deploy grappling hooks called PfEMP1 (plasmodium falciparum erythrocyte membrane protein 1) onto the outside of the red blood cells, latching ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.

The disease is caused by five species of Plasmodium parasites, with Plasmodium falciparum responsible for the most severe cases. In 2024 alone, malaria accounted for more than 250 million cases ...